WebIPO Profile: Symbol: GDRX: Exchange: NASDAQ: Shares (millions): 34.6: Price range: $33.00 - $33.00: Est. $ Volume: $1141.8 mil: Manager / Joint Managers: Morgan Stanley/ Goldman Sachs/ J.P. Morgan/ Barclays: ... such as changes in the proposed offering terms and the shifting of investor interest in the IPO. The information offered is taken from ... WebGoodRx Holdings (GDRX) will release its next earnings report on May 10, 2024. ... IPO Calendar Earnings Calendar. Popular. ... except where otherwise indicated, are presented gross-of fees and do not include the effect of backtested transaction costs, management fees, performance fees or expenses, if applicable. ...
GoodRx IPO: 6 Things for Potential GDRX Investors …
WebSep 17, 2024 · Analyzing Income Statement. – GDRX grew revenue from $99M in 2016 to $388M in 2024 (crazy growth) – Biggest operating expense currently: SG&A, which was 46% of revenues last year. – EPS grew from -$0.11 to $0.19 in four years (w/ growing share count) – 2024 EPS of $0.19 is computed using weighted average shares post-IPO. WebSep 23, 2024 · The company is expected to raise $570 million at a valuation of $10 billion. In its last fundraising round in 2024, GDRX was valued at $2.5 billion. GDRX’s IPO is going to give it more resources that will make its … flight reliability information
GoodRx shares jump 40% in Nasdaq debut after $1 billion IPO
WebJun 7, 2024 · The company did raise $1.1 billion during its initial public offering (or IPO) in September, but cash and equivalents were down to $932.5 million on March 31, so investors still have some time to ... WebGoodRx stock price target raised to $6.00 from $4.50 at UBS. Mar. 1, 2024 at 9:31 a.m. ET by Tomi Kilgore. WebGoodRx price target raised to $6 from $5.50 at Wells Fargo. Wells Fargo analyst Stan Berenshteyn raised the firm’s price target on GoodRx to $6 from $5.50 and keeps... 1M ago. GDRX. GoodRx sees Q1 revenue $181M-$183M, consensus $181.72M. Sees Q1 adjusted EBITDA margin mid-twenty-percent range. Published first on TheFly See today’s best ... chemo in a pill form